Renaissance Capital logo

EOLS News

What 2018’s IPOs Tell Us About 2H18

Evolus logo

Performance of IPOs priced year to date may provide direction for the rest of the year. Through May 31, 76 IPOs have priced producing returns of 24% from the IPO price, mostly from the first day pop. Fully 57% of the IPOs have been in the ...read more

US IPO Weekly Recap: Volatility shakes IPO market as 6 deals price and most break issue

WHD

Market volatility was back this week, and IPOs either dropped out or dropped their valuations. Six companies in five different sectors raised a combined $992 million, along with one SPAC. Four of the six deals priced below the midpoint of the range, and five...read more

Evolus prices IPO at $12, the low end of the range

Evolus logo

Evolus, which is preparing to launch a biosimilar version of Botox, raised $60 million by offering 5 million shares at $12, the low end of the range of $12 to $14. Evolus plans to list on the Nasdaq under the symbol EOLS. Cantor Fitzgerald and Mizuho...read more

US IPO Week Ahead: 10 deals expected with energy leading the way

QES

January's record-breaking activity is spilling over into February. Ten companies are targeting a combined $1.8 billion. Headlined by three energy companies, deals include an Argentine ag-tech, a Turkish Burger King franchisee, a Chinese wearables manufacturer,...read more